Suven Life Sciences Ltd. - Research Center
530239 SUVEN Group (B) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 20 | Jun' 20 | Mar' 20 | Sep' 19 | Jun' 19 | |
|---|---|---|---|---|---|
| Sales | 8.98 | 1.43 | 8.66 | 1.39 | 198.99 |
| Operating profit | -3.84 | -7.79 | -2.08 | -12.50 | 90.03 |
| Interest | 0.25 | 0.22 | 0.23 | 0.10 | 1.31 |
| Gross profit | -1.82 | -5.48 | 0.69 | -10.23 | 91.73 |
| EPS (Rs) | -0.15 | -0.32 | -0.20 | -0.88 | 4.49 |
Quarterly
results in details
| Sep' 20 | Jun' 20 | Mar' 20 | Sep' 19 | Jun' 19 | |
|---|---|---|---|---|---|
| Other income | 2.28 | 2.53 | 3.00 | 2.38 | 3.01 |
| Stock adjustment | - | - | - | - | -17.32 |
| Raw material | - | - | - | - | 58.66 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 4.86 | 3.41 | 3.48 | 4.20 | 18.75 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | 7.02 | 4.95 | 5.76 | 7.51 | 13.10 |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 0.94 | 0.86 | 1.49 | 2.18 | 35.76 |
| Provisions made | - | - | - | - | - |
| Depreciation | 1.07 | 1.06 | 1.05 | 1.42 | 5.55 |
| Taxation | -0.99 | -2.47 | 2.20 | -0.41 | 29.00 |
| Net profit / loss | -1.90 | -4.08 | -2.56 | -11.23 | 57.18 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 12.73 | 12.73 | 12.73 | 12.73 | 12.73 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -42.80 | -545.27 | -23.99 | -901.36 | 45.25 |
| GPM (%) | -16.17 | -138.45 | 5.90 | -271.41 | 45.41 |
| NPM (%) | -16.88 | -103.02 | -21.99 | -298.08 | 28.31 |
© 2020 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis